Stanford Cancer Institute Directory
Showing 251 - 260 of 463
Clinical Associate Professor, Radiology
Dr. Lipson is an investigator and faculty member in the Stanford University School of Medicine Department of Radiology, Breast Imaging Division. A graduate of Harvard College in 1995, she received her MD degree from UCSF School of Medicine, prior to completing a preliminary medicine internship year at St. Mary's Medical Center in San Francisco. She went on to complete a diagnostic radiology residency program at UCSF and was ABR board-certified in June 2009. She came to Stanford for a 1 year fellowship program in Breast Imaging in July 2009 before joining the MCL faculty in August 2010. Her clinical work includes screening and diagnostic mammography, diagnostic breast ultrasound, screening and diagnostic breast MRI, and minimally-invasive breast biopsy and wire localization guided by x-ray, ultrasound, and MRI. Her research interests include mammographic density and breast cancer risk assessment; early breast cancer detection and extent of disease evaluation using contrast enhanced mammography and MRI; novel blood and imaging biomarkers of breast cancer burden and neoadjuvant treatment response; and image-guided wireless localization techniques for breast surgery.
Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Associate Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center
Billy W. Loo, Jr., M.D., Ph.D. is an Associate Professor of Radiation Oncology, a member of the Molecular Imaging Program at Stanford (MIPS) in the Department of Radiology, and a member of the Stanford Cancer Institute, in the School of Medicine. He is a physician-scientist Radiation Oncologist and Bioengineer who leads the Thoracic Radiation Oncology Program at Stanford. His clinical specialties are state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy for lung tumors. Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member, chair, or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, including the National Comprehensive Cancer Network (NCCN), American College of Radiology (ACR), and American Society of Radiation Oncology (ASTRO). His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, development of new medical imaging methods for measuring organ function and predicting response to cancer treatment, and development of next generation radiation treatment technologies and studying their unique biological effects. As part of this work, he leads an active clinical and preclinical research program in molecular imaging, particularly using novel PET tracers for tumor hypoxia (EF5), tumor proliferation (FLT), and neuroinflammation (PBR06). Since conceiving of a fundamentally new approach to delivering ultra-rapid, ultra-precise radiation therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), Dr. Loo's major laboratory research focus has been to co-lead a collaborative effort between the Stanford Cancer Institute and SLAC National Accelerator Laboratory to develop PHASER into a transformative yet clinically practical technology. This program comprises both technology development and fundamental research on the radiobiology of extremely rapid FLASH radiation therapy to optimize the biological therapeutic index. Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University. He is certified by the American Board of Radiology in Radiation Oncology.
Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Dr. Lowsky has been an academic clinician and medical researcher in hematopoietic cell transplantation for 20 years and has broad experience and expertise in the field. He has designed, written, implemented and participated in single and multi-center federally-funded clinical trials; and has served on the Stanford IRB and SRC for cancer-oriented clinical trials for over 10 years.
Professor of Biomedical Data Science and, by courtesy, of Radiology (Molecular Imaging) and of Health Research and Policy (Epidemiology)